Next Article in Journal
An Optimized Synthesis, Molecular Structure and Characterization of Benzylic Derivatives of 1,2,4-Triazin-3,5(2H,4H)-dione
Previous Article in Journal
Design, Synthesis and Anticancer Evaluation of Fangchinoline Derivatives
Previous Article in Special Issue
Protein Interaction and Na/K-ATPase-Mediated Signal Transduction
Article Menu
Issue 11 (November) cover image

Export Article

Open AccessReview
Molecules 2017, 22(11), 1932;

Anticancer and Immunogenic Properties of Cardiac Glycosides

Programa de Pós-Graduação em Farmácia, Centro de Ciências da Saúde, Universidade Federal de Santa Catarina, Florianópolis, SC 88040-900, Brazil
Laboratoire de Biologie Moléculaire et Cellulaire du Cancer (LBMCC), Hôpital Kirchberg, 9, rue Edward Steichen, 2540 Luxembourg, Luxembourg
Department of Pharmacy, Research Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Building 29 Room 223, 1 Gwanak-ro, Gwanak-gu 08826, Korea
Author to whom correspondence should be addressed.
Received: 5 October 2017 / Revised: 29 October 2017 / Accepted: 4 November 2017 / Published: 8 November 2017
(This article belongs to the Special Issue Cardiotonic Steroids)
Full-Text   |   PDF [1449 KB, uploaded 9 November 2017]   |  


Cardiac glycosides (CGs) are natural compounds widely used in the treatment of several cardiac conditions and more recently have been recognized as potential antitumor compounds. They are known to be ligands for Na/K-ATPase, which is a promising drug target in cancer. More recently, in addition to their antitumor effects, it has been suggested that CGs activate tumor-specific immune responses. This review summarizes the anticancer aspects of CGs as new strategies for immunotherapy and drug repositioning (new horizons for old players), and the possible new targets for CGs in cancer cells. View Full-Text
Keywords: cardiac glycosides; anticancer; immunogenic cell death; cytotoxic effects; cancer cells; Na/K-ATPase cardiac glycosides; anticancer; immunogenic cell death; cytotoxic effects; cancer cells; Na/K-ATPase

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Schneider, N.F.Z.; Cerella, C.; Simões, C.M.O.; Diederich, M. Anticancer and Immunogenic Properties of Cardiac Glycosides. Molecules 2017, 22, 1932.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top